Anixa and OntoChem enter next stage of Covid-19 anti-viral therapy development

cafead

Administrator
Staff member
  • cafead   Apr 06, 2021 at 10:12: AM
via Biotechnology company Anixa Biosciences, partnered by IT and pharma solutions company OntoChem, has announced that it will enter the next stage of development of its potential anti-viral therapy for Covid-19.

article source
 

<